Published in
Elsevier, European Journal of Pharmaceutical Sciences, (181), p. 106345, 2023
DOI: 10.1016/j.ejps.2022.106345
Links
Tools
The PBPK LeiCNS-PK3.0 framework predicts Nirmatrelvir (but not Remdesivir or Molnupiravir) to achieve effective concentrations against SARS-CoV-2 in human brain cells
Journal article published in 2023 by
Mohammed A. A. Saleh 
,
M. A. A. E. W.; Hirasawa,
Makoto Hirasawa,
Elizabeth C. M. de Lange ,
Ming Sun,
M.; Berfin,
Berfin Gülave,
G.; Elassaiss,
Jeroen Elassaiss-Schaap,
J.; Lange,
E. C. M. De
,
M. A. A. E. W.; Hirasawa,
Makoto Hirasawa,
Elizabeth C. M. de Lange ,
Ming Sun,
M.; Berfin,
Berfin Gülave,
G.; Elassaiss,
Jeroen Elassaiss-Schaap,
J.; Lange,
E. C. M. De
This paper is made freely available by the publisher.
Full text: Download
Data provided by 